Tracking treatment outcomes for advanced breast cancer with a specific gene mutation

This is a real-world study that follows patients with a specific type of advanced breast cancer — one that has an ESR1 gene mutation and has stopped responding to hormone-based treatments. Researchers will collect information about what treatments patients receive and how well those treatments work, including any side effects. The goal is to understand which treatment approaches are most effective and safest for people with this particular form of breast cancer.

Many patients with this type of advanced breast cancer eventually stop responding to standard hormone therapy, leaving them with limited options. This study exists to understand what treatments doctors are actually using in real-world practice and how well they work, so that future patients can benefit from the most up-to-date information about their treatment choices.